Fake cancer drugs reveal gaps in healthcare system
Published · Updated
AI-generated summary of the coverage listed below: In recent months, counterfeit cancer medications have been found circulating in the market, prompting concerns about patient safety and regulatory oversight. The drugs, often marked by spelling errors, poor print quality, and unclear manufacturing dates, have been identified by doctors and pharmacists across the country. The incidents highlight weaknesses in supply chain monitoring and the need for stricter enforcement to protect patients from harmful, unapproved treatments.
Covered by 6 outlets across the spectrum: 17% left, 50% center, 33% right.
Who is covering this story
- Left-leaning (1): The Hindu
- Center (2): Deccan Herald, Mid-Day
- Right-leaning (2): Deccan Chronicle, Times Now
Sources
- Fake Meds That ‘Spell’ Trouble — Deccan Chronicle (right-leaning)
- Fake cancer drugs expose dangerous gaps in healthcare system — Deccan Herald (center)
- SC calls cancer drug overpricing ‘broad daylight dacoity’, flags 10-fold MRP — Mid-Day (center)
- SC calls cancer drug overpricing ‘broad daylight dacoity’, flags 10-fold MRP — Mid-Day (center)
- Karnataka to track cancer patients after fake drug bust — The Hindu (left-leaning)
- ₹27,000 Cancer Drug, ₹2,700 Retailer Price: What It Means For Cancer Patients — Times Now (right-leaning)